%0 Journal Article
%@ 1438-8871
%I JMIR Publications
%V 26
%N 
%P e51749
%T Reliability of Telepsychiatry Assessments Using the Attention-Deficit/Hyperactivity Disorder Rating Scale-IV for Children With Neurodevelopmental Disorders and Their Caregivers: Randomized Feasibility Study
%A Kurokawa,Shunya
%A Nomura,Kensuke
%A Hosogane,Nana
%A Nagasawa,Takashi
%A Kawade,Yuko
%A Matsumoto,Yu
%A Morinaga,Shuichi
%A Kaise,Yuriko
%A Higuchi,Ayana
%A Goto,Akiko
%A Inada,Naoko
%A Kodaira,Masaki
%A Kishimoto,Taishiro
%+ Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Mori JP Tower F7, 1-3-1, Azabudai, Minato-ku, Tokyo, 106-0041, Japan, 81 3 5363 3219, tkishimoto@keio.jp
%K acceptability
%K ADHD
%K application
%K attention-deficit/hyperactivity disorder
%K autism spectrum disorders
%K autism
%K child
%K children
%K diagnosis
%K management
%K neurodevelopmental disorder
%K neurodevelopmental
%K psychiatrists
%K reliability
%K telepsychitatry
%D 2024
%7 19.2.2024
%9 Original Paper
%J J Med Internet Res
%G English
%X Background: Given the global shortage of child psychiatrists and barriers to specialized care, remote assessment is a promising alternative for diagnosing and managing attention-deficit/hyperactivity disorder (ADHD). However, only a few studies have validated the accuracy and acceptability of these remote methods. Objective: This study aimed to test the agreement between remote and face-to-face assessments. Methods: Patients aged between 6 and 17 years with confirmed Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition diagnoses of ADHD or autism spectrum disorder (ASD) were recruited from multiple institutions. In a randomized order, participants underwent 2 evaluations, face-to-face and remotely, with distinct evaluators administering the ADHD Rating Scale-IV (ADHD-RS-IV). Intraclass correlation coefficient (ICC) was used to assess the reliability of face-to-face and remote assessments. Results: The participants included 74 Japanese children aged between 6 and 16 years who were primarily diagnosed with ADHD (43/74, 58%) or ASD (31/74, 42%). A total of 22 (30%) children were diagnosed with both conditions. The ADHD-RS-IV ICCs between face-to-face and remote assessments showed “substantial” agreement in the total ADHD-RS-IV score (ICC=0.769, 95% CI 0.654-0.849; P<.001) according to the Landis and Koch criteria. The ICC in patients with ADHD showed “almost perfect” agreement (ICC=0.816, 95% CI 0.683-0.897; P<.001), whereas in patients with ASD, it showed “substantial” agreement (ICC=0.674, 95% CI 0.420-0.831; P<.001), indicating the high reliability of both methods across both conditions. Conclusions: Our study validated the feasibility and reliability of remote ADHD testing, which has potential benefits such as reduced hospital visits and time-saving effects. Our results highlight the potential of telemedicine in resource-limited areas, clinical trials, and treatment evaluations, necessitating further studies to explore its broader application. Trial Registration: UMIN Clinical Trials Registry UMIN000039860; http://tinyurl.com/yp34x6kh 
%M 38373022
%R 10.2196/51749
%U https://www.jmir.org/2024/1/e51749
%U https://doi.org/10.2196/51749
%U http://www.ncbi.nlm.nih.gov/pubmed/38373022